My ISA Watch List: GlaxoSmithKline plc, Diageo plc And PZ Cussons plc

Why I’m watching GaxoSmithKline plc (LON: GSK), Diageo plc (LON: DGE) and PZ Cussons plc (LON: PZC) for this year’s ISA.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

From 6 April 2016, we get another ISA allowance of £15,240, and that’s a tax-free investment opportunity worth grabbing.

Leading with quality

I’m looking for firms that can pay a reliable and growing stream of dividends in the years to come. If the company has a quality business with strong cash flow, capital growth should follow. Expanding dividend payments and a rising share price mean a double win that should drive pleasing total returns.

Quality firms can go on my watch list waiting for a sensible entry point, such as during periods of general market weakness, or when a temporary issue knocks the firm’s share price.

Today’s focus is on GlaxoSmithKline (LSE: GSK), Diageo (LSE: DGE) and PZ Cussons (LSE: PZC). 

Defensive attributes

These firms attract because of their defensive qualities. GlaxoSmithKline, the pharmaceutical giant, trades in an industry characterised by consistent demand, and people often repeat-purchase the firm’s products. That set-up tends to generate reliable flows of cash for GlaxoSmithKline. Meanwhile, Diageo’s alcoholic drinks output also feeds into a consumer-driven market. People come back repeatedly for their favourite tipple and that translates into a reliable cash stream for Diageo.

PZ Cusson’s portfolio of consumable goods brands in the personal care, home care, beauty, food and nutrition markets is also a great cash generator. The common theme linking these three firms is that they all sell stuff that people need over and over again, profitably.

Outlooks

In February, GlaxoSmithKline’s chief executive said: “For 2016, we continue to expect core EPS percentage growth to reach double-digits on a constant currency basis, although we are also mindful that the macroeconomic and healthcare environment will continue to be challenging.”

Despite possible headwinds, GlaxoSmithKline looks set to lumber through 2016 and beyond. The firm announced a special dividend for 2015 and that strikes me as a good indicator that the firm remains in good health.

In January, Diageo’s chief executive said: “While trading conditions remain challenging in some markets, Diageo’s brands, capabilities in marketing and innovation and our route to consumer have proved resilient. I am confident that Diageo can deliver improved, sustained performance.”

Diageo’s top man is confident that the drinks provider can keep powering forward and so am I. The firm operates in an attractive industry and enjoys substantial economic moats with its popular brands.

Commenting on the firm’s interim results in January, PZ Cussons’ chairman said: These are a steady set of results in what have been challenging markets with overall revenue and profitability broadly flat versus the comparative period. We remain confident about the medium and long-term opportunities which should begin to materialise.”

I’m also confident that PZ Cussons’ business model will keep it afloat and steady in difficult times, and growing nicely in the good times.

All three of these firms operate good quality, cash-generating and enduring businesses, and because of that, their valuations tend to look a little pricey at times. However, buying on dips, down days and during times of general market malaise can be one way of building up a position in the longer-term growth stories on offer. That’s why I think they’re good candidates for my ISA watch list.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any shares mentioned. The Motley Fool UK owns shares of PZ Cussons. The Motley Fool UK has recommended Diageo and GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Caucasian woman with pink her studying from her laptop screen
Investing Articles

These 3 growth stocks still look dirt cheap despite the FTSE hitting all-time highs

Harvey Jones is hunting for growth stocks that have missed out on the recent FTSE 100 rally and still look…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Investing Articles

Here’s how much I’d need to invest in UK income stocks to retire on £25k a year

Harvey Jones is building his retirement plans on a portfolio of top UK dividend income stocks. There are some great…

Read more »

Investing Articles

If I’d invested £5,000 in BT shares three months ago here’s what I’d have today

Harvey Jones keeps returning to BT shares, wondering whether he finally has the pluck to buy them. The cheaper they…

Read more »

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

Here’s how I’d aim for a million, by investing £150 a week

Our writer outlines how he’d aim for a million in the stock market through regular saving, disciplined investing, and careful…

Read more »

Investing Articles

Here’s how the NatWest dividend could earn me a £1,000 annual passive income!

The NatWest dividend yield is over 5%. So if our writer wanted to earn £1,000 in passive income each year,…

Read more »

Young female hand showing five fingers.
Investing Articles

I’d start buying shares with these 5 questions

Christopher Ruane shares a handful of selection criteria he would use to start buying shares -- or invest for the…

Read more »

Businessman use electronic pen writing rising colorful graph from 2023 to 2024 year of business planning and stock investment growth concept.
Investing Articles

Here’s how much income I’d get if I invested my entire £20k ISA in Tesco shares

Harvey Jones is wondering whether to take the plunge and buy Tesco shares, which offer solid growth prospects and a…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

1 big-cap stock I’d consider buying with the FTSE 100 around 8,000

With several contenders it’s been a tough choice. But here are my top FTSE 100 stock picks, despite the buoyant…

Read more »